Cargando…
Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial
OBJECTIVES: Our objective was to compare prostate cancer detection rates between patients undergoing serum prostate-specific antigen (PSA) vs magnetic resonance imaging (MRI) for prostate cancer screening. DESIGN: Phase III open-label randomised controlled trial. SETTING: Single tertiary cancer cent...
Autores principales: | Nam, Robert, Patel, Chirag, Milot, Laurent, Hird, Amanda, Wallis, Christopher, Macinnis, Patrick, Singh, Mala, Emmenegger, Urban, Sherman, Christopher, Haider, Masoom A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644313/ https://www.ncbi.nlm.nih.gov/pubmed/36351725 http://dx.doi.org/10.1136/bmjopen-2021-059482 |
Ejemplares similares
-
Role of mpMRI of the prostate in screening for prostate cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2017) -
Complications after surgery for benign prostatic enlargement: a population-based cohort study in Ontario, Canada
por: Matta, Rano, et al.
Publicado: (2019) -
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
por: Nordström, Tobias, et al.
Publicado: (2019) -
A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design
por: Freedland, Stephen J, et al.
Publicado: (2021) -
The Predictive Value of Prostate-Specific Antigen Density: A Retrospective Analysis of Likert 3 Multiparametric MRI of the Prostate
por: Feyisetan, Oladapo, et al.
Publicado: (2023)